相关实验视频
Updated: Jun 21, 2025

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
临床实践和疾病的差异在老年发病和长期老年性结肠炎之间的过程:一个单一的中心研究在日本
Motoi Sawahashi1, Rintaro Moroi1, Yoichi Kakuta1
1Division of Gastroenterology, Tohoku University Graduate School of Medicine.
老年发疹性结肠炎 (UC) 患者需要更多的免疫抑制疗法,包括全身类固醇和分子向药物,与长期UC患者相比. 这表明老年人发病UC的疾病过程更具侵略性.
科学领域:
- 胃肠病学 胃肠病学
- 免疫抑制是一种免疫抑制.
- 老年医学 老年医学
背景情况:
- 对于老年性结肠炎 (UC) 患者的最佳免疫抑制疗法尚未明确定义.
- 将老年开始UC (EOUC) 与长期老年UC (LEUC) 进行比较,可以澄清临床实践和预后.
研究的目的:
- 评估和比较老年UC患者的临床实践和预后.
- 要区分EOUC (发病年龄≥60岁) 和LEUC (发病年龄<60岁).
主要方法:
- 对60岁以上的UC患者进行了回顾性单中心队列研究.
- 从诊断到2022年8月收集的数据.
- 评估了系统性类固醇的累积率,分子向药物 (MTD) 启动率和胆管切除率.
主要成果:
- 在EOUC组中,系统性类固醇 (46%对1年22%) 和MTD (17%对1年5%) 的累积率较高.
- 老年发病与全身类固醇 (HR 2.74) 和MTD (HR 2.76) 开始显著相关.
- 两组之间累积切除术率没有显著差异.
结论:
- 患有EOUC的患者在疾病发病后更早开始服用全身类固醇和MTD.
- 研究结果表明,在老年UC患者中,癌症的进展和折射性很快.
- 在这个人群中优化免疫抑制疗法的影响.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...